Optimal First Line Treatment of EGFR+ Advanced NSCLC: Osimertinib vs. Standard of Care EGFR TKIs and Chemo

By GRACE FEATURING Jack West
By GRACE FEATURING Jack West
558 views
July 22, 2019
Comments 0
Login to view comments. Click here to Login